Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND.

Chalermchai T, Valcour V, Sithinamsuwan P, Pinyakorn S, Clifford D, Paul RH, Tipsuk S, Fletcher JL, Degruttola V, Ratto-Kim S, Hutchings N, Shikuma C, Ananworanich J; SEARCH 007 and 011 study groups.

J Neurovirol. 2013 Apr;19(2):137-43. doi: 10.1007/s13365-013-0151-4. Epub 2013 Mar 13.

2.

Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.

Marin-Webb V, Jessen H, Kopp U, Jessen AB, Hahn K.

PLoS One. 2016 Dec 19;11(12):e0168225. doi: 10.1371/journal.pone.0168225. eCollection 2016.

3.

A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.

Joska JA, Witten J, Thomas KG, Robertson C, Casson-Crook M, Roosa H, Creighton J, Lyons J, McArthur J, Sacktor NC.

AIDS Behav. 2016 Aug;20(8):1621-31. doi: 10.1007/s10461-016-1316-y.

4.

Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery.

de Almeida SM, Kamat R, Cherner M, Umlauf A, Ribeiro CE, de Pereira AP, Franklin D, Heaton RK, Ellis RJ.

J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):332-338. doi: 10.1097/QAI.0000000000001224.

PMID:
27828876
5.

Validity of the International HIV Dementia Scale in South Africa.

Joska JA, Westgarth-Taylor J, Hoare J, Thomas KG, Paul R, Myer L, Stein DJ.

AIDS Patient Care STDS. 2011 Feb;25(2):95-101. doi: 10.1089/apc.2010.0292. Epub 2011 Jan 7.

PMID:
21214343
6.

Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy.

Skinner S, Adewale AJ, DeBlock L, Gill MJ, Power C.

HIV Med. 2009 Apr;10(4):246-52. doi: 10.1111/j.1468-1293.2008.00679.x. Epub 2009 Jan 23.

7.

Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.

Cross S, Önen N, Gase A, Overton ET, Ances BM.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1114-22. doi: 10.1007/s11481-013-9505-1. Epub 2013 Oct 10.

8.

The International HIV Dementia Scale: a new rapid screening test for HIV dementia.

Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E.

AIDS. 2005 Sep 2;19(13):1367-74.

PMID:
16103767
9.

HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project.

Ku NS, Lee Y, Ahn JY, Song JE, Kim MH, Kim SB, Jeong SJ, Hong KW, Kim E, Han SH, Song JY, Cheong HJ, Song YG, Kim WJ, Kim JM, Smith DM, Choi JY.

HIV Med. 2014 Sep;15(8):470-7. doi: 10.1111/hiv.12137. Epub 2014 Feb 24.

10.

Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South Africa.

Goodkin K, Hardy DJ, Singh D, Lopez E.

J Neuropsychiatry Clin Neurosci. 2014 Fall;26(4):352-8. doi: 10.1176/appi.neuropsych.13080178.

PMID:
26037857
11.

Validity of the International HIV dementia scale in Brazil.

Rodrigues RA, Oliveira RL, Grinsztejn B, Silva MT.

Arq Neuropsiquiatr. 2013 Jun;71(6):376-9. doi: 10.1590/0004-282X20130042.

12.

[An exploratory study on the diagnostic cutoff value of International HIV-associated Dementia Scale in minority ethnic groups with different educational levels, in Guangxi].

Zhao TT, Feng QM, Liang H, Tang XY, Wei B.

Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Nov;32(11):1101-4. Chinese.

PMID:
22336543
13.

Prevalence of neurocognitive disorders and depression in a Brazilian HIV population.

Troncoso FT, Conterno Lde O.

Rev Soc Bras Med Trop. 2015 Jul-Aug;48(4):390-8. doi: 10.1590/0037-8682-0034-2015.

14.

The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon.

Njamnshi AK, Djientcheu Vde P, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WE.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):393-7.

PMID:
19186351
15.

Adding a brief self-report cognitive tool to the IHDS improves effectiveness of identifying patients with HIV-associated dementia in South Africa.

Gouse H, Casson-Crook M, Decloedt EH, Joska JA, Thomas KGF.

J Neurovirol. 2017 Oct;23(5):686-695. doi: 10.1007/s13365-017-0551-y. Epub 2017 Jul 26.

PMID:
28748448
16.

Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study.

Atashili J, Gaynes BN, Pence BW, Tayong G, Kats D, O'donnell JK, Ndumbe PM, Njamnshi AK.

BMC Neurol. 2013 Jul 15;13:86. doi: 10.1186/1471-2377-13-86.

17.

The HIV Dementia Scale: predictive power in mild dementia and HAART.

Bottiggi KA, Chang JJ, Schmitt FA, Avison MJ, Mootoor Y, Nath A, Berger JR.

J Neurol Sci. 2007 Sep 15;260(1-2):11-5. Epub 2007 May 4.

PMID:
17482212
18.

A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale.

Haddow LJ, Floyd S, Copas A, Gilson RJ.

PLoS One. 2013 Apr 16;8(4):e61826. doi: 10.1371/journal.pone.0061826. Print 2013. Review.

19.

Validity of the International HIV Dementia Scale as assessed in a socioeconomically underdeveloped region of Southern China: assessing the influence of educational attainment.

Dang C, Wei B, Long J, Zhou M, Han X, Zhao T.

Int J Infect Dis. 2015 Apr;33:56-61. doi: 10.1016/j.ijid.2014.12.042. Epub 2014 Dec 30.

20.

Diagnostic accuracy of the International HIV Dementia Scale and HIV Dementia Scale: A meta-analysis.

Hu X, Zhou Y, Long J, Feng Q, Wang R, Su L, Zhao T, Wei B.

Exp Ther Med. 2012 Oct;4(4):665-668. Epub 2012 Aug 14.

Supplemental Content

Support Center